Abstract:The ideal food for new-borns is human breast milk, a mixture that provides a balanced combination of nutrients and bioactive components. Seeking to emulate maternal milk more effectively, this study assesses the impact of incorporating a multi-strain synbiotic and/or osteopontin (an active biopeptide) on the intestinal health of lactating pigs. Ninety-six weaned piglets were assigned to four dietary treatments in a 2x2 design. Treatments included: standard milk formula (CTR); CTR + probiotics (6.4x108 cfu/L Bifidobacterium longum subsp. infantis CECT 7210 and 1.1x108 cfu/L Lactobacillus rhamnosus NH001) + prebiotics (galacto-oligosaccharides 4.36 g/L and human-milk-oligosaccharide 0.54 g/L) (SYN); CTR + osteopontin (0.43 g/L) (OPN); and CTR + SYN + OPN (CON). Daily records including feed intake, body weight, and clinical signs, were maintained throughout the 15-day trial. Samples from blood, digestive content, and gut tissues were collected to determine serum TNF-α, intestinal fermentation (SCFA and ammonia), colonic microbiota (16S rRNA Illumina-MiSeq), histomorphology, and jejunal gene expression (Open-Array). No statistical differences were found in weight gain; however, animals supplemented with osteopontin exhibited higher feed intake. Regarding clinical signs, synbiotic supplementation led to shorter duration of diarrhoea episodes. The sequenced faecal microbiota revealed better control of potentially dysbiotic bacteria with CON diet at day 15. In colon compartment, an increase in SCFA concentration, a decrease in ammonia concentration, and a decrease in intraepithelial lymphocyte counts were observed in CON animals. Supplemented diets were also associated with modified jejunal gene expression. The synbiotic combination exhibited an upregulation of genes related to intestinal maturation (ALPI, SI) and nutrient transport (SLC13A1, SLC15A1, SLC5A1, SLC7A8), and downregulation of genes related to the response to pathogens (GBP1, TLR4) or inflammatory response (IDO, IL-1β, TGF-β1). Osteopontin promoted an upregulation of a digestive function gene (GCG). Correlational analysis between the microbiota population and various intestinal environmental factors (SCFA concentration, histology, and gene expression) proposes mechanisms of communication between the gut microbiota and the host. In summary, these results suggest an improvement in the colonic colonization process and a better modulation of the immune response when milk formula is supplemented with the tested synbiotic combined with osteopontin, benefiting from a synergistic effect.

A YOUNG CHILD FORMULA SUPPLEMENTED WITH L. REUTERI AND GALACTO-OLIGOSACCHARIDES MODULATES THE COMPOSITION AND FUNCTION OF THE GUT MICROBIOME SUPPORTING BONE AND MUSCLE DEVELOPMENT IN TODDLERS

A young child formula supplemented with a synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V improves the gut microbiota and iron status in healthy toddlers

Probiotic infant cereal improves children's gut microbiota: Insights using the Simulator of Human Intestinal Microbial Ecosystem (SHIME®)

Efficacy and safety of a synbiotic infant formula for the prevention of respiratory and gastrointestinal infections: a randomized controlled trial

Early-Life Supplementation Enhances Gastrointestinal Immunity and Microbiota in Young Rats

Effect of protein modification in synbiotic infant formula on probiotic metabolic activity and bacterial composition in an infant gut-model

Galacto-oligosaccharide preconditioning improves metabolic activity and engraftment of Limosilactobacillus reuteri and stimulates osteoblastogenesis ex vivo

Tenth year reenrollment randomized trial investigating the effects of childhood probiotics and calcium supplementation on height and weight at adolescence

Impact of probiotic Limosilactobacillus reuteri DSM 17938 on amino acid metabolism in the healthy newborn mouse

Effects of infant formula supplemented with prebiotics compared with synbiotics on growth up to the age of 12 mo: a randomized controlled trial

Diurnal rhythmicity of fecal microbiota and metabolite profiles in the first year of life: a randomized controlled interventional trial with infant formula

Effects of a Formula with scGOS/lcFOS (9:1) and Glycomacropeptide (GMP) Supplementation on the Gut Microbiota of Very Preterm Infants

Bifidobacterium animalis subsp. lactis BL-11 Promotes Height Growth in Children Aged 3-7 Years: A Self-controlled Cohort Study

Effect of Probiotic-Fortified Infant Formula on Infant Gut Health and Microbiota Modulation

An A2 β-casein infant formula with high sn-2 palmitate and casein phosphopeptides supports adequate growth, improved stool consistency, and bone strength in healthy, term Chinese infants: a randomized, double-blind, controlled clinical trial

Growth patterns of 11 to 29-month-old children consuming young child formula: secondary analysis of a randomized, controlled study

Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial

Microbiota Supplementation with Bifidobacterium and Lactobacillus Modifies the Preterm Infant Gut Microbiota and Metabolome: An Observational Study

Comparative evaluation of enriched formula milk powder with OPO and MFGM vs. breastfeeding and regular formula milk powder in full-term infants: a comprehensive study on gut microbiota, neurodevelopment, and growth

Supplementing infant milk formula with a multi-strain synbiotic and osteopontin enhances colonic microbial colonization and modifies jejunal gene expression in lactating piglets

Infant Formula Supplemented With Milk Fat Globule Membrane, Long-Chain Polyunsaturated Fatty Acids, and Synbiotics Is Associated With Neurocognitive Function and Brain Structure of Healthy Children Aged 6 Years: The COGNIS Study